Antipsychotic Combinations vs. Monotherapy in Schizophrenia: A Meta-Analysis of Randomized Controlled Trials |
2010-08-05 |
Guideline Recommendations for the Diagnosis and Treatment of Adult ADHD without Comorbidity
|
2010-09-02 |
Latest Updates From The Agency for Health Care Administration |
2010-09-02 |
New Developments in the Treatment of Depression 2008-2009
|
2010-09-02 |
At the Crossroads of Medicine and Policy: Psychotherapeutic Medications for Children
|
2010-09-02 |
Updated Florida Best Practice Medication Guidelines for Adults
|
2010-09-02 |
New Recommendations for Youth with Neurodevelopmental Disorders Now Available Electronically
|
2014-01-09 |
News from the Agency for Health Care Administration To Medicaid Providers
|
2010-09-02 |
Christoph Correll et al. Antipsychotic Combinations vs. Monotherapy in Schizophrenia |
2010-09-22 |
DISCUS and AIMS Scales
|
2010-09-23 |
Florida Pediatric Psychiatry Hotline
|
2012-06-08 |
Barry Sarvet et al. Improving Access to Mental Health Care for Children
|
2011-01-13 |
Regarding the Use of Ziprasidone in Children and Adolescents
|
2011-04-11 |
Don't Give Up Take Action! |
2011-01-03 |
Provider Alert Psychotherapeutic Consent
|
2011-07-25 |
FDA Safety Information for Celexa and Saphris
|
2011-09-07 |
Henderson Behavioral Health Awarded $1.6 million SAMHSA Primary Care and Behavioral Healthcare Integration Grant
|
2012-10-12 |
Psychotherapeutic Medication Guidelines for Children and Adolescents Updated
|
2013-02-11 |
Doctors Prescribe Drugs as Neuro-enahncements?
|
2013-04-01 |
Antipsychotic Polypharmacy Prescribing Patterns and Costs in the Florida Adult and Child Medicaid Populations |
2013-10-15 |
Feds Probe Antipsychotic Prescriptions For Children In Medicaid |
2013-08-14 |
FDA is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv
|
2013-07-01 |
Florida Best Practice Medication Guidelines Survey Results
|
2013-06-19 |
Florida Medicaid Health Information Network Powered by Availity |
2013-05-07 |
ZYPREXA
|
2010-09-02 |
SEROQUEL
|
2010-09-02 |
New research finding: Cognitive therapy effective in reducing symptoms in people with schizophrenia spectrum disorders |
2014-02-21 |
The IMPACT study provides a model for managing SGA-related weight gain in children |
2014-02-21 |
2014 MDTMP implements a Clozapine Peer Support Project with the Boley Centers and Henderson Behavioral Health
|
2014-02-21 |
NEW 2014 Psychotherapeutic Medication Guidelines for Adults
|
2014-02-27 |
2014 Psychotherapeutic Medication Guidelines for Neurodevelopmental Disorders in Youth
|
2014-02-28 |
Recent research findings on AP use in Medicaid-insured youth |
2014-04-10 |
Newsletter Summer 2014 - Program Highlights and Updates
|
2014-09-08 |
The FDA has approved the supplemental New Drug Applications for paliperidone palmitate (Invega Sustenna) to treat schizoaffective disorder as either monotherapy or adjunctive therapy. |
2014-11-18 |
New study published on first-episode psychosis
|
2014-12-12 |
2015 Winter Newsletter - Program Updates
|
2015-01-13 |
Spring 2015 Newsletter
|
2015-05-26 |
AHCA Medicaid Quality Issue Briefs |
2015-06-02 |
The Risks and Benefits of Switching Patients with Schizophrenia or Schizoaffective Disorder from Two to One Antipsychotic Medication: A Randomized Controlled Trial. Robert J. Constantine et al. |
2015-09-24 |
Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians. Michael J Ostacher et al. |
2015-09-24 |
Clozapine Changes Summary
|
2015-10-06 |
New Adult Psychotherapeutic Medication Guidelines Coming Soon
|
2015-10-06 |
Summer / Fall 2015 Newsletter
|
2015-10-06 |
Vraylar Snapshot
|
2015-10-09 |
Rexulti Snapshot
|
2015-10-09 |
Psychotherapeutic Medication Use in the Florida Pediatric Population and Integrated Care: Presentation by Dr. B. Sahasranaman at the Florida Medical Association Annual Meeting 2015
|
2015-10-13 |
Clozapine REMS Program Deadline Extension |
2015-11-19 |
Free Upcoming Webinar - January 22, 2016
|
2016-01-08 |
FCAAP Regional Meeting - Miami
|
2016-03-04 |
Free Upcoming Webinar - March 24, 2016
|
2016-03-14 |
Free Upcoming Webinar - April 12, 2016
|
2016-03-25 |
Updated Guidelines Coming Soon!
|
2016-03-31 |
FCAAP Regional Meeting - Jacksonville
|
2016-04-13 |
Free Upcoming Webinar - May 6, 2016
|
2016-04-24 |
Clozapine FDA Updates
|
2016-04-27 |
Brintellix (vortioxetine) - Brand Name Change to Trintellix |
2016-05-03 |
Abilify - FDA Announcement (05.03.2016) |
2016-05-04 |
FCAAP Regional Meeting - Tallahassee
|
2016-05-06 |
Florida Clozapine Hotline: 727-562-6762
|
2016-05-26 |
FDA Drug Safety Podcast: Rare skin reaction with olanzapine |
2016-06-01 |
FDA Drug Safety Podcast: Impulse control problems associated with aripiprazole |
2016-06-01 |
FDA Drug Safety Podcast: Brintellix (vortioxetine) name change |
2016-06-01 |
May 2016 Newsletter
|
2016-06-07 |
Logo Design Contest!
|
2016-08-04 |
Antipsychotics During Pregnancy Not Tied to Birth Defects |
2016-08-22 |
Pregnancy & Birth Outcomes of Women with SMI Compared to Women without SMI in Florida Medicaid - Provider Survey Report
|
2016-11-21 |
Pregnancy & Birth Outcomes of Women with SMI Compared to Women without SMI in Florida Medicaid - Database Report
|
2016-11-21 |
Opioid Summit (Tampa) – Jan 19, 2017
|
2016-12-14 |
FDA working to resolve challenges with the Clozapine REMS Program |
2016-12-19 |
FCAAP Regional Meeting - Hollywood, FL
|
2017-02-22 |
Free Webinar on DMDD - March 15, 2017
|
2017-02-22 |
February 2017 Newsletter
|
2017-03-06 |
Free Webinar - March 29, 2017
|
2017-03-06 |
Free Webinar - April 26
|
2017-04-06 |
Monitoring the Physical Health Side Effects of Psychiatric Medications
|
2017-04-10 |
FCAAP Meeting - Orlando (May 4)
|
2017-04-25 |
FCAAP Meeting - Tallahassee (May 3)
|
2017-04-25 |
FCAAP Meeting - St. Petersburg (May 2)
|
2017-04-25 |
FCAAP Meeting - Jacksonville (May 18)
|
2017-04-25 |
National Mental Health Awareness Month
|
2017-05-10 |
Free Webinar - May 30
|
2017-05-17 |